Peter J Barnes1, Stanley J Szefler2, Helen K Reddel3, Bradley E Chipps4. 1. National Heart & Lung Institute, Imperial College, London, United Kingdom. Electronic address: p.j.barnes@imperial.ac.uk. 2. Paediatric Asthma Research Program and the Breathing Institute, Children's Hospital Colorado, and the Department of Pediatrics, University Colorado School of Medicine, Aurora, Colo. 3. Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia. 4. Capital Allergy & Respiratory Disease Center, Sacramento, Calif.
Abstract
BACKGROUND: Asthma causes the unpleasant sensation of breathlessness (dyspnea) caused by airway obstruction. Patients with poor perception of airway obstruction are at risk of delay in seeking medical attention and undertreatment, which can lead to avoidable deaths. Conversely, those with heightened perception are at risk of overtreatment and iatrogenic adverse effects with reliever medications, anxiety, and unnecessary use of health care resources. OBJECTIVE: We sought to review evidence about symptom misperception in asthmatic patients and how to identify and manage affected patients, particularly with regard to reliever medications. METHODS: We conducted a systematic literature search for studies of perception of airway function in asthmatic patients. We searched the OVID (Medline and Medline [R] in process [PubMed]), Embase, and Adisearch/Odyssey databases, restricting our search to human studies published in English from 1990-2018, with no restrictions on age, sex, or racial origin. RESULTS: We found that both underperception and overperception assessed during induced bronchoconstriction or bronchodilation or during changes in airway resistance were common across all age groups and that aging, disease severity, smoking, sex, ethnicity, psychologic factors, and medication are all associated with differences in perception. Importantly, airway inflammation was associated with impaired perception and a history of severe or near-fatal asthma. We also identified knowledge gaps, such as whether an individual patient's perception varies over time and the influence perception has on patients' use of reliever medication. CONCLUSION: We found that abnormal perception of airway obstruction has important clinical implications for the management of patients with asthma.
BACKGROUND:Asthma causes the unpleasant sensation of breathlessness (dyspnea) caused by airway obstruction. Patients with poor perception of airway obstruction are at risk of delay in seeking medical attention and undertreatment, which can lead to avoidable deaths. Conversely, those with heightened perception are at risk of overtreatment and iatrogenic adverse effects with reliever medications, anxiety, and unnecessary use of health care resources. OBJECTIVE: We sought to review evidence about symptom misperception in asthmatic patients and how to identify and manage affected patients, particularly with regard to reliever medications. METHODS: We conducted a systematic literature search for studies of perception of airway function in asthmatic patients. We searched the OVID (Medline and Medline [R] in process [PubMed]), Embase, and Adisearch/Odyssey databases, restricting our search to human studies published in English from 1990-2018, with no restrictions on age, sex, or racial origin. RESULTS: We found that both underperception and overperception assessed during induced bronchoconstriction or bronchodilation or during changes in airway resistance were common across all age groups and that aging, disease severity, smoking, sex, ethnicity, psychologic factors, and medication are all associated with differences in perception. Importantly, airway inflammation was associated with impaired perception and a history of severe or near-fatal asthma. We also identified knowledge gaps, such as whether an individual patient's perception varies over time and the influence perception has on patients' use of reliever medication. CONCLUSION: We found that abnormal perception of airway obstruction has important clinical implications for the management of patients with asthma.
Authors: Juan P Wisnivesky; Jacqueline H Becker; Jyoti Ankam; Steven B Markowitz; Molly Doernberg; Brittany Dickens; Paula Busse; Laura Crowley; Alex Federman; Craig Katz; Jeffrey J Weiss; Adam Gonzalez Journal: J Allergy Clin Immunol Pract Date: 2021-09-14
Authors: Audrey Fossati; Caroline Challier; Aman Allah Dalhoumi; Javier Rose; Annick Robinson; Caroline Perisson; François Galode; Baptiste Luaces; Michael Fayon Journal: Healthcare (Basel) Date: 2022-06-17
Authors: Jonathan M Feldman; Jacqueline Becker; Arushi Arora; Jesenya DeLeon; Tatiana Torres-Hernandez; Naomi Greenfield; Allyana Wiviott; Sunit Jariwala; Chang Shim; Alex D Federman; Juan P Wisnivesky Journal: Psychosom Med Date: 2021-09-01 Impact factor: 3.864
Authors: Angelica Tiotiu; Iulia Ioan; Nathalie Wirth; Rodrigo Romero-Fernandez; Francisco-Javier González-Barcala Journal: Int J Environ Res Public Health Date: 2021-01-23 Impact factor: 3.390
Authors: Helen K Reddel; Leonard B Bacharier; Eric D Bateman; Christopher E Brightling; Guy G Brusselle; Roland Buhl; Alvaro A Cruz; Liesbeth Duijts; Jeffrey M Drazen; J Mark FitzGerald; Louise J Fleming; Hiromasa Inoue; Fanny W Ko; Jerry A Krishnan; Mark L Levy; Jiangtao Lin; Kevin Mortimer; Paulo M Pitrez; Aziz Sheikh; Arzu A Yorgancioglu; Louis-Philippe Boulet Journal: Eur Respir J Date: 2021-12-31 Impact factor: 16.671
Authors: Alison Moore; Andrew Preece; Raj Sharma; Liam G Heaney; Richard W Costello; Robert A Wise; Andrea Ludwig-Sengpiel; Giselle Mosnaim; Jamie Rees; Ryan Tomlinson; Ruth Tal-Singer; David A Stempel; Neil Barnes Journal: Eur Respir J Date: 2021-06-04 Impact factor: 33.795